Medical Equipment

Transmucosal Drug Delivery Devices Market Insights: Revenue Expected to Surpass $76.06 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the transmucosal drug delivery devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Transmucosal Drug Delivery Devices Market?

The transmucosal drug delivery devices market size has seen significant growth in recent years. This market is set to increase from $50.24 billion in 2024 to $54.63 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the past can be attributed to the necessity for swift relief from angina, the efficiency of sublingual delivery for rapid bloodstream absorption, the desire to avoid gastrointestinal degradation, the innovation of buccal tablets, and the demand for non-invasive administration of peptides and proteins.

The transmucosal drug delivery devices market is anticipated to experience substantial growth over the next few years. It is projected to expand to $76.06 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expected growth during the forecast period is attributable to the advancement of smart drug delivery systems, a rising incidence of chronic diseases, an increasing emphasis on personalized medicine, an aging population with elevated medication requirements, and heightened awareness. Significant trends for the forecast period include an expansion in therapeutic applications, the tailoring of drug delivery devices for personalized medicine, evolving regulatory approvals and guidelines, the emergence of new markets, the development of eco-friendly devices, and the creation of innovative formulations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp

Which Growth Drivers Are Propelling The Transmucosal Drug Delivery Devices Market?

The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the transmucosal drug delivery devices market moving forward. A chronic illness is characterized as a long-term ailment that typically develops slowly and persists over an extended period, frequently necessitating ongoing medical care to manage its symptoms and avert complications. The rise in chronic diseases can be attributed to factors such as lifestyle choices, an aging populace, environmental influences, challenges within healthcare systems, and increasing urbanization. Transmucosal drug delivery devices find application in chronic conditions by enabling precise and effective medication dispersion, which helps sustain therapeutic concentrations for symptom management and enhances patient adherence. For instance, in August 2023, a report from the US-based charitable organization, the Leukemia & Lymphoma Society (LLS), indicated that in the US, roughly every three minutes, an individual receives a diagnosis of leukemia, lymphoma, or myeloma. For 2023, approximately 184,720 people are projected to be diagnosed with these conditions, which constitutes 9.4% of the forecasted 1,958,310 new cancer diagnoses for the year. Consequently, the expanding prevalence of chronic diseases is a key factor driving the transmucosal drug delivery devices market.

Which Segmentation Factors Are Most Significant In The Transmucosal Drug Delivery Devices Market Analysis?

The transmucosal drug delivery devicesmarket covered in this report is segmented –

1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery

2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types

3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications

4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals

Subsegments:

1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems

2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation

Which Notable Trends Are Transforming The Transmucosal Drug Delivery Devices Market Outlook?

Leading companies in transmucosal drug delivery devices are innovating smart platforms, such as proprietary transdermal patch delivery systems, which are designed to enhance drug absorption and improve patient compliance and convenience. Proprietary transdermal patch delivery platforms represent specialized, company-owned technologies for administering medications through the skin, ensuring controlled release and improved therapeutic outcomes. For instance, in January 2024, Starton Therapeutics Inc, a US-based biotechnology company, introduced STARSILON, a new proprietary transdermal patch delivery platform, intended for longer duration to achieve the therapeutic delivery of active pharmaceutical ingredients (APIs) that are difficult to formulate. This expands transdermal drug delivery options for challenging APIs, thereby enhancing therapeutic efficacy with sustained delivery rates.

Who Are The Most Influential Companies In The Transmucosal Drug Delivery Devices Market?

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/transmucosal-drug-delivery-devices-global-market-report

Which Region Holds The Largest Share In The Transmucosal Drug Delivery Devices Market Today?

North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=16812&type=smp

Browse Through More Reports Similar to the Global Transmucosal Drug Delivery Devices Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Injectable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795